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Abstract
Introduction
Cardiopulmonary exercise testing (CPET) is widely used within the United Kingdom for pre-
operative risk stratification. Despite this, CPET’s performance in predicting adverse events
has not been systematically evaluated within the framework of classifier performance.
Methods
After prospective registration on PROSPERO (CRD42018095508) we systematically identi-
fied studies where CPET was used to aid in the prognostication of mortality, cardiorespira-
tory complications, and unplanned intensive care unit (ICU) admission in individuals
undergoing non-cardiopulmonary surgery. For all included studies we extracted or calcu-
lated measures of predictive performance whilst identifying and critiquing predictive models
encompassing CPET derived variables.
Results
We identified 36 studies for qualitative review, from 27 of which measures of classifier per-
formance could be calculated. We found studies to be highly heterogeneous in methodology
and quality with high potential for bias and confounding. We found seven studies that pre-
sented risk prediction models for outcomes of interest. Of these, only four studies outlined a
clear process of model development; assessment of discrimination and calibration were per-
formed in only two and only one study undertook internal validation. No scores were exter-
nally validated. Systematically identified and calculated measures of test performance for
CPET demonstrated mixed performance. Data was most complete for anaerobic threshold
(AT) based predictions: calculated sensitivities ranged from 20-100% when used for predict-
ing risk of mortality with high negative predictive values (96-100%). In contrast, positive
predictive value (PPV) was poor (2.9-42.1%). PPV appeared to be generally higher for
cardiorespiratory complications, with similar sensitivities. Similar patterns were seen for the
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association of Peak VO2 (sensitivity 85.7-100%, PPV 2.7-5.9%) and VE/VCO2 (Sensitivity
27.8%-100%, PPV 3.4-7.1%) with mortality.
Conclusions
In general CPET’s ‘rule-out’ capability appears better than its ability to ‘rule-in’ complica-
tions. Poor PPV may reflect the frequency of complications in studied populations. Our cal-
culated estimates of classifier performance suggest the need for a balanced interpretation
of the pros and cons of CPET guided pre-operative risk stratification.
Introduction
There is increasing focus on the identification of the ‘high-risk’ surgical patient. Large scale
national projects such as the ‘National Emergency Laparotomy Audit’ (NELA) incorporate
this pre-operative assessment of risk into pathways to stratify perioperative care [1]. In the
elective setting techniques including risk scales, patient function, organ biomarkers, and levels
of comorbidity have all been used with the aim of risk stratifying patients [2]. Risk stratifica-
tion may facilitate precision interventions to improve outcome in this patient cohort, as well as
assist in the process of shared decision making. Cardiopulmonary exercise testing (CPET) is
attractive as a basis for patient stratification as it represents an objective and holistic physiolog-
ical assessment of cardiopulmonary reserve. Briefly, an individual exercises (typically on a
cycle) in a graded manner whilst simultaneous measurements of inspired, and expired gases,
heart rate, and electrocardiogram are made [3]. Numerous objective summaries of cardiopul-
monary function can be derived from CPET including the oxygen consumption at the anaero-
bic threshold (AT), maximal oxygen consumption (VO2Max, a plateau in oxygen uptake at
maximal exercise levels), ‘Peak VO2’,(or the highest oxygen uptake recorded in a sub-maximal
test), as well as ventilatory equivalents for both oxygen (VE/ VO2) and carbon dioxide (VE/
VCO2) [4].
In 1993 it was reported that an AT of<11ml/kg/min accurately identified patients at risk of
cardiovascular mortality undergoing intra-abdominal surgery [5]. Subsequent work by the
same group utilised this finding to guide perioperative care, with high risk patients undergoing
major surgery allocated to high dependency (HDU) or intensive care unit (ICU) beds [6].
Importantly, this work also demonstrated that a single metric alone may not be adequately dis-
criminating. Patients with AT of>11mL/Kg/min but with evidence of myocardial ischaemia
during CPET testing, or with severe pulmonary disease also suffered cardiopulmonary mortal-
ity and the overall numbers of deaths was low. Patients deemed to be ‘fit’ on CPET with an AT
of>11mL/Kg/min and with no myocardial ischaemia had no instances of cardiac mortality.
The authors themselves suggest that CPET is “even more reliable at detecting those not at
risk. . .” [6].
More recently, CPET has been used to characterise individuals with chronic cardiac or
respiratory failure [7] and, especially in the United Kingdom (UK), is being increasingly used
for the stratification of patients prior to high risk procedures [8]. With nearly 15,000 individual
tests a year from 2011 [9], this represents a significant logistical, organisational, and financial
undertaking with the National Institute for Health and Care Excellence (NICE) quoting an
average unit cost of £183 [10].
CPET is often used to gate access to more advanced care (such as intensive care unit admis-
sion) [6]. This strategy, of referring those identified as high risk using CPET to elective critical
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care stay, could have serious consequences if, in fact, the positive predictive value of CPET is
poor. Critical care bed capacity is under incredible pressure [11] and unnecessary utilisation
could add further strain to an already stretched system. Furthermore lack of critical care beds
is already a significant risk factor for day of surgery cancellation [12], if this admission is based
on the result of information with poor predictive performance this could lead to an unneces-
sary delay in an individual’s care. The issue of predictive performance is also important when
decisions not to operate. Treatment options could be limited based on an individual being
judged high risk but this result may in fact poorly predict the occurrence of complications. In
a survey of practice the majority of respondents did not recommend cancellations based on
CPET results but a significant minority (33%) did or, based on free-text comments, used these
tests to inform subsequent discussions between clinical staff and the patient [9]. In their 2016
update on preoperative investigation NICE failed to make specific recommendations regard-
ing the use of CPET but noted that other simpler, and cheaper tests may also be used for risk
prediction [10]. For these reasons, the performance of CPET as a prognostic test should be
carefully evaluated, as with other tests, in terms of its ability to correctly (or incorrectly) iden-
tify patients with and without the outcome of interest [13]. If CPET is used to identify an
adverse outcome of interest within some time frame then the statistical interpretation of test
performance can be performed using methods familiar from diagnostic testing [14]. Many of
these (such as sensitivity, or specificity) are well known. However, no single metric can fully
encapsulate a tests performance [15] and it is vital to recognise the potential consequences of
false positives and negatives within the specific clinical context.
Numerous systematic reviews of the perioperative utility of CPET have been performed
[16–18]. These have highlighted the breadth of current work and concluded that CPET
appeared to have promise as a marker of outcome amongst certain specialties [16, 17] but not
all [18]. Formal meta-analysis has not been performed due to the heterogeneity of summary
data and outcomes, making proper comparison difficult. The use of prediction models in med-
icine for diagnostic, and prognostic purposes to aid in patient decision making, and targeting
of resources to high risk individuals is now widespread [19]. Despite CPET’s potential utility
in these roles we are unaware of a systematic appraisal of generated prediction models that
incorporate information from CPET testing.
In this work we aimed to identify newly published studies assessing CPET’s prognostic
capabilities for cardiorespiratory complications, 30 day or in-hospital death, and unplanned
intensive care unit admission for non-cardiopulmonary surgery. These outcomes were chosen
a priori based on their relevance to the underlying physiology under test (Cardiorespiratory
complications), their importance and examination in initial CPET studies (Mortality) [5], and
that elective critical care admission is often advocated for CPET determined high risk cases [6]
(unplanned ICU admission). As an extension over previously published systematic reviews we
set out to generate comparable metrics of CPET test performance from the published data to
aid clinicians in interpreting its performance as a prognostic test. Finally, for studies present-
ing a risk model using regression techniques, we aimed to provide the first evaluation of the
methodological quality of these models using a validated approach [20].
Materials and methods
Search strategy
A systematic search strategy was developed in consultation with a medical librarian. We com-
bined keywords for cardiorespiratory complications featured in the European Perioperative
Clinical Outcome (EPCO) definitions [21] by the European Society of Anesthesiology (ESA)
and the European Society of Intensive Care Medicine (ESICM), death and unplanned ICU
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admission. Further keywords to identify the perioperative period and cardiopulmonary exer-
cise testing were also used. Medical Subject Headings (MeSH) terms were used as appropriate.
Both Medline and Embase databases were searched on March 22nd 2017 using the Ovid inter-
face. Due to the length of time required for study identification and data extraction the search
was rerun on July 24th 2018 with new, applicable studies included. After initial submission the
search was re-run on 2nd December 2019 for calendar years 2018 and 2019 to ensure our find-
ings were current. PROSPERO registration was obtained (CRD42018095508). Full details of
the search strategy is given in S1 Appendix. Titles and abstracts were screened for full-text
inclusion by DJS and LAG. In cases of dispute inclusion was determined by arbitration by AE.
References of included studies were then searched to identify further studies. Full numbers of
studies identified and analysed at each stage are shown in the PRISMA diagram in Fig 1.
Outcomes
We included studies where CPET was used to identify the risk of the following outcomes. Mor-
tality (in-hospital/peri-operative and within 30 days of surgery), unplanned ICU admission,
and complications affecting the cardiorespiratory systems. Studies looking at cardiorespiratory
complications must have looked at the occurrence of at least one of the complications featured
in the EPCO list of perioperative outcomes [21]. Our initial plan was that each study must fol-
low the strict definitions incorporated within this document. However, it became apparent
that this would lead to us including very few studies. Therefore studies were included as long
as they looked at the occurrence of a complication featured in the list of cardiorespiratory
complications or used one of the cited composite outcome measures (e.g. the Postoperative
Morbidity Score—POMS). We included studies where cardiorespiratory complications were
presented as a pooled outcome but not if they were included with other organ system compli-
cations (e.g. cardiorespiratory complications as judged using POMS was accepted, ‘any POMS
positive’ was not).
Fig 1. PRISMA diagram demonstrating identification of included studies. Panel A demonstrates those included from initial
search, Panel B those from repeat search. Meta-analysis refers to those included in calculation of confusion matrix metrics.
https://doi.org/10.1371/journal.pone.0226480.g001
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Inclusion and exclusion criteria
Our pre-specified inclusion criteria for analysis were: Any primary research paper using CPET
derived variables to aid in identification of adult (aged 18 or over) patients at risk of one of our
pre-defined outcomes of interest. Studies could be prospective or retrospective in their design.
Patients must have been undergoing non-cardiopulmonary surgery. Our exclusion criteria
were: papers where complications were analysed as a pooled outcome, those that were not pub-
lished in a peer-reviewed journal or available only as an abstract, review articles or correspon-
dence. Only studies written in English were included. Previous meta-analyses on the subject
were identified and their references, along with those of included studies, were searched for
suitable studies for inclusion.
Data extraction
Risk of bias was assessed using the ‘Quality in Prognostic Studies’ (QUIPS) tool [22]. This was
performed independently by DJS and LAG with arbitration of any conflicts undertaken by dis-
cussion between all three authors. Papers where a multivariable logistic regression model con-
taining CPET derived variables was generated for one of our declared outcomes were also
critiqued using the validated prognostic model checklist ‘CHARMS’ [20]. For all studies, we
recorded whether a significant association was found for CPET variables and chosen out-
comes, we also noted the statistical methodology used. We also extracted reported sensitivities
and specificities for CPET variables. To supplement these published values we also data mined
included papers to generate our own confusion matrices. In this process a ‘true positive’ was
defined as a patient who had a CPET value categorising them as high-risk and suffered the out-
come in question. A ‘true negative’ was a patient whose CPET variables categorised them as
low-risk and did not suffer the specified adverse outcome. Our generated confusion matrices
are available in supplementary material (S1 Table. We also recorded any AUC (area under the
receiver operator curve) values for CPET and other prognostic variables reported in the paper.
As a secondary aim we undertook the above process for other examined prognostic variables
(e.g. American Society of Anesthesiologists- ASA score) within each paper. All data extraction
was performed independently by DJS and LAG.
Prediction performance metrics
After generating confusion matrices for each study, classifier performance was evaluated on
the basis of sensitivity, specificity, positive predictive value (PPV), negative predictive value
(NPV), accuracy, F1 score, and Matthews Correlation Coefficient (MCC). The F1 score is the
harmonic mean between a tests PPV and sensitivity and ranges between 0 (worst perfor-
mance) and 1 (perfect performance). To score highly a test must have both a high PPV and
should miss very few cases (high sensitivity). The MCC is a correlation coefficient between
predictions and outcomes and can be interpreted analogously to the Pearson’s product
moment correlation coefficient [23]. It incorporates all domains of the contingency table and
therefore all classifier outcomes contribute equally to its calculation (i.e. misclassification of
both positive and negative cases are important to its calculation). It ranges between -1 (test is
always wrong) to +1 (test is always correct) with 0 indicating a performance no better than
chance. Although our initial protocol dictated that we would attempt to generate summary
receiver operator characteristic curves (SROC) their calculation demonstrated significant data
heterogeneity that would render their findings invalid and, as such, were not included in this
article.
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Results
Study characteristics
Our initial search identified 534 records for screening with a further 24 identified through cita-
tion searching: These constituted 490 unique records. In total, 28 studies were included for
qualitative review, from which classifier values could be extracted from 25. Our search was
updated on two occasions. Initially, four new studies were included for qualitative analysis,
including one paper where its inclusion proceeded after contacting the authors for unpub-
lished data [24]. One of these studies was included in classifier analysis. A repeat search prior
to publication identified four further studies from one of which measures of classifier perfor-
mance could be calculated [25]. In total we therefore present results from 36 studies, with clas-
sifier values calculated from 27. Full inclusion and exclusion information is demonstrated in
Fig 1. Studies covered multiple surgical specialities. Nine studies were performed in colorectal
patients, six in vascular, six in upper gastrointestinal, six in hepatobiliary, six in mixed ‘major
surgical populations’, two in urological, and one each in transplant and bariatric populations.
Full details of all studies is shown in Table 1. The median number of study participants was
105 [Interquartile range 72-199]. 10 (28%) of studies were blinded meaning in the majority of
studies (26/36–72%) information from CPET was either definitely or potentially used to guide
the care of study participants (e.g. by stratifying admission to intensive care). In one study
[26], despite not being blinded it was stated that CPET did not directly influence care. 23
(64%) of studies were performed prospectively. 28 studies looked at mortality as an outcome
with 14 studies reporting on risk of combined cardiorespiratory morbidity. six studies
reported purely cardiovascular complications, four respiratory complications, and six studies
looked at rates of unplanned ICU admission. Risk of bias assessment for included studies, per-
formed using the QUIPS checklist is shown in S1 Fig.
Selection of patients for CPET testing varied between studies. In two cases patients were
selected for CPET on the basis of low levels of estimated functional capacity on a validated
questionnaire. 12 studies used an age threshold for gating access to CPET, in seven of these a
lower age threshold was used if the individual suffered from specific comorbidities (normally
cardiovascular or diabetes). In five cases [27–31] we felt it was impossible to determine, due to
phrasing of the papers or study design, exactly who was selected to undergo CPET and whether
eligible participants might have been missed. In one study the inclusion criteria changed
throughout the inclusion period from being selected on the basis of comorbidity to being con-
secutive. For details see Table 1.
CPET variables and statistical significance
Studies looked at a variety of CPET derived variables. 33 studies (92%) looked at AT, 11
(31%) VE/VCO2, 11 (31%) the Peak VO2, and five (15.6%) VO2 Max. Numerous other vari-
ables including cardiac ischaemia, oxygen pulse, work rates, chronotropic incompetence,
and combined metrics were looked at by smaller numbers of studies. Details of all CPET
variables studied in individual papers is shown in Table 1. No variable was found to be con-
sistently statistically significant between studies. 17 of 33 studies (51.5%) found a significant
association between AT and a pre-specified outcome of interest, 5/11 (45.4%) found associa-
tions between Peak VO2, 4/11 (36.4%) VE/VCO2, and 2/5 (40%) VO2 Max. Of note, despite
all studies utilising either a retrospective or prospective cohort design only one study uti-
lised measures of relative risk [32]. None utilised Poisson or time-to-event statistical
methods.
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Table 1. Summary of included studies in systematic review of the performance of cardiopulmonary exercise testing (CPET) for identification of post-operative out-
comes of interest n = 33.
Study (Year)
[Ref]
N Specialty Outcomes Blinded Prospective Altered
care
Selection for CPET Variables Statistics
Older (1993)
[5]
187 Major Surgery Mortality (Total
and CVS)
N Y Y Consecutive age 60+ AT�
Ischaemia�
Chi-Sq
Nugent (1998)
[44]
36 Vascular:AAA Cardiorespiratory
Mortality
Y Y N Patients a/w repair
Excl. MSK or IC
AT
Peak VO2
O2 Pulse
Ischaemia
M-W, Chi-Sq
Older(1999) [6] 548 Major
Abdominal
Mortality (CVS and
Other)
N Y Y >60
<60 + previous
Myocardial
ischaemia. Excl.
Thoracic (incl. UGI)
AT Descriptive
Nagamatsu
(2001) [37]
91 Oesophagectomy Cardiorespiratory N N Unclear Surgery for SCC Excl.
Neo-adjuvant
chemotherapy, CCF,
COPD
VO2 Max
�
AT
T-T M-W
McCullough
(2006) [45]
109 Bariatric Mortality
Cardiorespiratory
(MI, Angina, PE)
Y Y N BMI�35 (+DM) or
�40 for lap. roux-en-
Y bypass. Excl.
Limiting angina, lung
disease
Peak VO2 Descriptive
(excluding analysis
for composite
outcome of death
and complications)
Bowles(2008)
[28]
124 Colorectal Mortality N N Y Over 60 with
‘recognised heart/
lung disease’, post
anaesthetic
assessment
AT Log. Regression
Forshaw(2008)
[46]
78 Oesophagectomy Mortality
Unplanned ICU
Cardiopulmonary
N Y Unclear Consecutive AT
VO2 peak
�
T-T Fisher’s
Struthers(2008)
[47]
50 Major abdominal Mortality(30D) N Y Possibly Over 65 having
‘major intra-
abdominal surgery’
Under 65 with
significant
myocardial
ischaemia, respiratory
disease, or CCF. Excl.
unstable CVS disease
AT Sens/Spec
(calculated)
Snowden
(2010) [48]
123 Major abdominal Mortality
Cardiopulmonary
N Y Y For ‘major surgery’
with METS score�
Excl. Colorectal,
Urological, and
Orthopaedic surgery
AT� Chi-sq
Wilson(2010)
[32]
847 Colorectal
Urology
Mortality N N Y >55
<55 +
cardiorespiratory
comorbidity or DM
AT�
VE/VCO2
�
RR
Thompson
(2011) [49]
66 Vascular Mortality(30D)
Cardiac (+ Stroke),
Respiratory
N N Y All patients AT�
VE/VCO2
VE/VO2
�
OR (incl. non
operative) AT sig.
mortality VE/VO2
sig. inotropic
requirement
Ausania (2012)
[26]
124 Hepatobiliary Mortality
Cardiorespiratory
N Y N Patients scoring <7
on a MET score
AT Chi-sq
Hartley (2012)
[29]
415 Vascular Mortality(30D) N Y Unclear ?All undergoing
open/EVAR
AT�
VE/VCO2�
�2 abnormal�
Peak VO2�
Chi-sq
(Continued)
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Table 1. (Continued)
Study (Year)
[Ref]
N Specialty Outcomes Blinded Prospective Altered
care
Selection for CPET Variables Statistics
Junejo [33]
(2012)
94 Hepatic Mortality (30D+in-
hospital)
Cardiorespiratory
N Y Y >65
<65 ‘with
comorbidity’, or
‘complex resection’
AT�
VE/VCO2�
OR AT sig. in-hosp
mortality, VE/VCO2
sig. cardiorespiratory
only
Chandrabalan
[50] (2013)
100 Pancreatic Mortality (incl.
operative), Cardiac,
Respiratory
N N Y Patients for
pancreatic surgery
AT Chi-sq
Goodyear
(2013) [30]
85 Vascular:AAA
Infrarenal
Mortality(30D) N N Y Consecutive (not all)
patients
AT� Fisher’s
Lai (2013) [51] 269 Colorectal Mortality(30D)
Unplanned ICU
N Y Y All major colorectal AT�
“Unable to
achieve AT”
Chi-sq
Moyes (2013)
[52]
180 Upper GI Mortality
Cardiorespiratory
Unplanned ICU
N Y Y Consecutive after
MDT discussion
AT�
VO2 peak
T-T (AT sig. for
Cardiorespiratory
only)
Prentis (2013)
[53]
69 Cystectomy Mortality Y Y N Consecutive AT Descriptive
Snowden[35]
(2013)
389 Hepatobiliary Mortality Y Y N All for open resection AT�
Peak VO2�
Peak Work�
VE/VCO2
VO2/HR
Chi-sq
Ting(2013) [34] 70 Renal Transplant Unplanned ICU Y Y N All >18
Excl.’condition
precluding exercise’
AT�
PeakVO2
�
O2 Pulse
�
Max Work�
Endurance time
VE/VCO2 slope
Log. regression
Dunne (2014)
[24]
197 Hepatectomy Mortality In
hospital
Cardiorespiratory
N N Y Initially >65 +
‘significant
comorbidity’, or
extended op.
Changed to all
patients
AT
Peak VO2
VE/VCO2
VE/VO2
Calculated%
James(2014)
[39]
83 Major surgery Mortality Cardiac Outcome Y Possibly Over 40s AT�
VO2 Peak
�
?T-T
Junejo (2014)
[38]
64 Pancreatic Mortality
Cardiorespiratory
N Y Unclear >65 Younger with
comorbidity
AT
VE/VCO2
�
VO2Max
Log. regression
Mortality only
West(BJA
2014) [54]
136 Colorectal Cardiorespiratory
(D5)
Y Y N All over 18 excl:
neoadjuvant, IBD,
inability to perform
AT�, Chi-Sq Fisher’s
West (EJSO
2014) [55]
25 Colorectal (post
NACRT)
Cardiorespiratory Y Y N Surgery post NACRT
—main aim to assess
impact of NACRT on
fitness
AT Sens/Spec
(calculated)
Barakat(2015)
[27]
130 Vascular Mortality Cardiac
Respiratory
N Y Y Most patients with
AAA>55, able to use
treadmill
AT�
VO2 Max
VE/VCO2
�
Log. regression AT
sig. cardiac only VE/
VCO2 sig. resp. only
Chan (2015)
[56]
94 Colorectal Mortality(30D),
Unplanned ICU
N N Y Subset of patients
>80 at surgeons
discretion
AT�
VO2 Max
�
MW (sig. ICU only)
Nikolopoulous
(2015) [57]
89 Colorectal Cardirespiratory
Mortality
N N Unclear Consecutive (Open
procedures)
AT� T-T M-W
(Cardioresp. only)
(Continued)
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Prediction performance metrics
27 studies either presented sensitivity and specificity or presented data in a format that allowed
us to calculate these and other performance measures by generating confusion matrices. These
studies, values, outcomes, and CPET cut-offs are presented in Table 2. Due to the multitude of
surgical specialities, outcome definitions, and differences in defined populations who under-
went CPET we did not generate ‘average’ values of each metric for each outcome. Instead this
Table 1. (Continued)
Study (Year)
[Ref]
N Specialty Outcomes Blinded Prospective Altered
care
Selection for CPET Variables Statistics
West [58]
(2016)
703 Colorectal Mortality (30D+In
hosp.)
Cardiorespiratory
(D5)
N Y Y Patients for major
colorectal, excl: lower
limb dysfunction,
IBD, neoadjuvant
treatment, metastatic
AT� Fisher’s
Kanakaraj
(2017) [59]
70 Vascular
Peripheral
Mortality(30D),
Cardiac
Y Y N Those for elective/
expedited infra-
inguinal bypass
surgery
AT
Peak VO2
VE/VCO2
T-T M-W
Whibley (2018)
[31]
73 Upper GI Respiratory N N Unclear Subset of those pre-
assessed, part of an
enhanced recovery
protocol
AT
VO2 Max
Chi-sq
Abbott (2019)
[41]
1324 Major non-
cardiac
Myocardial injury
D1-3
Y Y Safety
only
Over 70 OR Over 40
with higher risk
surgery or
comorbidity
Chronotropic
Incompetence
Log regression
Drummond
[25] (2019)
42 Oesophagectomy Cardiorespiratory,
30D Mortality,
Unplanned ICU
N Y Unclear Selected patients with
pre/post
chemotherapy prior
to oesophagectomy
for adenocarcinoma
AT
(Pre/Post
Chemotherapy)
Chi-sq
Lam (2019)
[36]
206 Oesophagectomy Cardiorespiratory Y N Possibly Consecutive
undergoing
oesophagectomy for
cancer. Excluded 40
who didn’t undergo
CPET for unclear
reasons
AT
Peak VO2
T-T
Wilson (2019)
[60]
1375 Colorectal Unplanned ICU N N Y Over 55 or younger
with
cardiorespiratory risk
factors
VE/VCO2 Log regression
30D = 30 Day, AAA = Abdominal aortic aneurysm, AT = Anaerobic Threshold, BMI = Body Mass Index, CCF = Congestive Cardiac Failure, Chi-Sq = Chi-Square test,
COPD = Chronic Obstructive Pulmonary Disease. CPET = Cardiopuulmonary Exercise Testing, CVS = Cardiovascular system, DM = Diabetes Mellitus,
EVAR = Endovascular Aneurysm Repair, IC = Intermittent claudication, ICU = Intensive care unit, lap. = laparoscopic, METS = Metabolic equivalents, MDT = Multi-
disciplinary Team, MI = Myocardial Infarction, N = number of patients who underwent and/or were analysed as having had CPET and may differ from the total
number of patients included in some studies, NACRT = Neoadjuvant chemo-radiotherapy, Chi-Sq = Chi- squared test, M-W = Mann-Whitney test,
MSK = musculoskeletal pathology, OR = Odd’s Ratio, PE = Pulmonary embolism, RR = Relative Risk, SCC = Squamous cell carcinoma, Sens/Spec = Sensitivity/
Specificity, T-T = Student’s T-Test, VE/VCO2, VE/VO2 = Ventilatory equivalents of carbon dioxide/oxygen, VO2 Max = Maximal oxygen uptake. Where stated D refers
to postoperative day. Italics indicate supporting information or exclusion criteria
� next to a CPET variable indicates it was found to be significant (using methods in statistical methods column.
‘Unclear’ was used to indicate if it was not possible to determine whether CPET values could have impacted on any aspect of patient care and thus introduced
confounding. Statistical methods/CPET variables shown are those pertaining to our specified outcomes of interest only. ‘Sens/Spec (calculated)’ demonstrates that we
extracted data pertaining to these CPET variables and outcomes and no formal testing was presented within the paper. % Indicates that analysis was performed on data
requested from the authors after not being presented in the primary paper.
https://doi.org/10.1371/journal.pone.0226480.t001
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Table 2. Confusion matrix metrics for CPET derived cardiorespiratory variables.
Study Outcome CPET Variable/Cutoff Sensitivity Specificity PPV NPV Accuracy F1 MCC
Chan [56] Mortality CPET Group 20.0 47.2 2.1 91.3 45.7 0.04 -0.15
Hartley [29] 30D Mortality VE/VCO2 42 42.9 80.5 7.1 97.6 79.2 0.12 0.11
Hartley [29] 30D Mortality Peak VO2 15 85.7 47.9 5.4 98.9 49.2 0.10 0.12
Hartley [29] 30D Mortality 2 or more abnormal 85.7 59.1 6.8 99.2 60.0 0.13 0.16
Hartley [29] 30D Mortality AT 10.2 78.6 55.1 5.8 98.7 55.9 0.11
Goodyear [30] 30D Mortality AT<11 (or unable to achieve) 50.0 88.9 18.2 97.3 87.1 0.27 0.25
Older [5] 1993 IP CVS Mortality AT 11 90.1 74.4 18.2 99.2 75.4 0.30 0.34
Older [5] 1993 IP CVS Mortality AT 11 + Ischaemia 88.9 68.6 42.1 96.0 72.7 0.57 0.47
Older [5] 1993 IP CVS Mortality Ischaemia 81.8 80.1 20.5 98.6 80.2 0.33 0.34
Wilson [32] In-hospital mortality AT 10.9 88.9 46.8 3.5 99.5 47.7 0.07 0.10
Wilson [32] In-hospital mortality VE/VCO2 34 83.3 48.5 3.4 99.3 49.2 0.07 0.09
Wilson [32] In-hospital mortality VE/VCO2 42 27.8 88.5 5.0 98.3 87.2 0.08 0.07
Ausania [26] In-hospital mortality AT 10.1 20.0 84.0 5.0 96.2 81.4 0.08 0.02
Junejo [33] 30D mortality AT 9.35 67.0 83.0 - - - - -
Junejo [33] 30D mortality AT 9.9 100 74.0 - - - - -
Junejo [33] In Hosp mortality AT 9.35.0 40.0 83.0 - - - - -
Junejo [33] In Hosp mortality AT 9.9 100 76.0 - - - - -
Junejo[38] 30D mortality VE/VCO2 41 100 92.0 - - - - -
Junejo [38] In Hosp mortality VE/VCO2 41 75.0 93.0 - - - - -
Lai [51] 30D Mortality AT 11 40.0 71.8 2.9 98.3 71.2 0.05 0.04
Lai [51] 30D Mortality Unable to get AT 44.4 91.5 15.4 97.9 90.0 0.23 0.22
McCullough [45] Mortality Peak VO2 15.8 100 66.7 2.7 100 67.0 0.05 0.13
Struthers [47] Mortality(30D) AT 11 100 68.4 7.7 100 69.2 0.14 0.22
Prentis [53] Mortality AT 12 100 58.2 6.7 100 59.4 0.13 20
Chandrabalan [50] Mortality AT 10.0 42.9 50.5 6.1 92.2 50.0 0.11 -0.03
Nugent [44] Mortality Peak VO2 20 100 44.8 5.9 100 46.7 0.11 0.16
Drummond [25] Operative mortality AT 9 28.6 82.1 44.4 69.7 64.3 0.35 0.12
Drummond [25] Operative mortality AT 11 0 41.5 0 94.4 40.5 0 -0.18
James [39] MACE AT 10.6 75.0 85.0 - - - - -
James [39] MACE Peak VO2 14 88.0 69.0 - - - - -
Snowden [48] 2010 Cardiac AT 10.1 86.7 62.4 25.5 96.9 65.5 0.39 0.33
West [54] BJA MI/Arrhythmia AT 10.1 64.7 55.4 17.2 91.7 56.6 0.27 0.13
West [55] EJSO Arrhythmia AT 10.7 100 50.0 7.7 100 52.0 0.14 0.20
Chandrabalan [50] Cardiac (CD III-IV) AT 10 100 51.5 2.0 100 52 0.04 0.10
West [58] Cardiovascular AT 11.1 72.2 60.4 4.6 98.8 60.7 0.09 0.11
Ausania [26] Cardiorespiratory AT 10.1 33.3 85.2 15.0 94.2 81.4 0.21 0.13
Forshaw [46] Cardiorespiratory AT 11 23.3 88.9 58.3 63.5 62.7 0.33 0.16
Moyes [52] Cardiorespiratory AT 9 37.9(45) 79.7(30) 42.3 76.6 68.0 0.4 0.18
Moyes [52] Cardiorespiratory AT 11 69.0(74) 50.0(57) 35.1 80.4 55.3 0.47 0.17
Nikolopolous [57] Cardiorespiratory AT 11 76.0 59.0 - - - - -
Nagamatsu [37] Cardiorespiratory VO2 Max 800 58.8 91.9 62.5 90.7 85.7 0.61 0.92
Junejo [38] Cardiorespiratory VE/VCO2 34.5 50.0 81.5 - - - - -
Junejo [33] Cardiorespiratory VE/VCO2 36.5 39.5 90.7 - - - - -
McCullough [45] Cardiorespiratory Peak VO2 15.8 50.0 66.7 5.4 97.2 66.2 0.10 0.07
Nugent [44] Cardiorespiratory PeakVO220 57.1 43.4 23.5 76.9 46.7 0.33 0.01
Drummond [25] Cardiorespiratory AT 9 38.9 83.3 63.6 64.5 64.3 0.48 0.25
Drummond [25] Cardiorespiratory AT 11 61.1 45.8 45.8 61.1 52.4 0.52 0.07
West [54] BJA Pneumonia AT 10.1 83.3 56.5 15.6 97.2 58.9 0.26 0.23
(Continued)
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table summarises ranges based on the outcomes of: mortality (all timescales up-to 30 days),
cardiac complications alone, respiratory complications alone, combined morbidity, and
unplanned ICU admission.
The most complete information was available for AT. For mortality, sensitivity values for
AT ranged from 0-100%, specificity ranged from 41.5% to 92%. NPV of AT for mortality had a
high estimated range (94.4-100%) which was higher than that for PPV (0–44.4%). These values
are presented graphically in the boxplot in Fig 2 along with corresponding ranges for cardiore-
spiratory complications, and unplanned ICU admission. The range for MCC values was -0.18-
0.47. F1 values ranged between 0 and 0.57.
For Peak VO2 as a predictor of mortality the sensitivity was consistently high ((85.7% to
100% from three studies) with correspondingly high NPV figures (98.9%–100%). Specificity
ranged from 44.8% to 66.7%. F1 scores ranged between 0.05 and 0.11 (reflecting PPV values of
2.7% to 5.9%), MCC was between 0.12 and 0.16.
VE/VCO2 demonstrated a wide range of sensitivities for predicting mortality ((27.8% to
100%)) with specificity of 48.5% to 93.0%. NPV was consistently above 97% and PPV between
3.4% and 7.1%. All MCC, and F1 values were 0.12 or lower. Data from more than one study
was available for Peak VO2, and VE/VCO2 as predictors of mortality, these are graphically
demonstrated in S2 Fig. Values for other CPET variables are shown in Table 2.
Logistic regression models and CHARMS checklist
Seven studies generated a multivariable model for one of our pre-specified outcomes using, or
including, CPET derived variables (Table 3). We critiqued these studies using the CHARMS
checklist. All were derived from Cohort studies, four of which were prospective [27, 33–35],
two were retrospective [36, 37], and in one case it was unclear [29]. Two studies generated a
model to predict mortality, four cardiorespiratory complications, and one unplanned ICU
admission. The populations from which the models were generated varied by surgical
Table 2. (Continued)
Study Outcome CPET Variable/Cutoff Sensitivity Specificity PPV NPV Accuracy F1 MCC
West [55] EJSO Pneumonia AT 10.7 100 52.2 15.4 100 56.0 0.27 0.28
Snowden [48] 2010 Pulmonary AT 10.1 74.4 71.4 56.9 84.6 72.4 0.64 0.44
Chandrabalan [50] Respiratory (CD III-IV) AT 10 57.1 51.6 8.2 94.1 52.0 0.14 0.04
West [58] Respiratory AT 11.1 76.3 64.2 21.4 95.5 65.6 0.34 0.26
Ting [34] Unplanned ICU AT 11.3 93.0 75.0 - - - - -
Chan [56] Unplanned ICU CPET group 33.3 64.3 16.7 81.8 58.8 0.22 -0.02
Forshaw [46] Unplanned ICU AT 11 23.1 84.1 25.0 85.4 74.7 0.24 0.09
Lai [51] Unplanned ICU AT 11 39.1 72.3 13.0 92.0 69.5 0.20 0.08
Prentis [53] Unplanned ICU AT 12 60.0 70.6 16.7 94.7 69.6 0.26 0.19
Drummond [25] Unplanned ICU AT 9 35.7 78.6 45.4 71.0 64.3 0.40 0.15
Drummond [25] Unplanned ICU AT 11 71.4 50.0 41.7 77.8 57.1 0.53 0.20
Outcome refers to study specified outcome of interest, CPET variable and cutpoint for values presented. Units for cutoffs: AT = ml/kg/min, Peak VO2 = ml/kg/min, VO2
Max = ml/min/m2, VE/VCO2 = Slope of curve between minute ventilation and CO2 production. PPV = Positive predictive value, NPV = Negative predictive value,
F1 = F1 Score, MCC = Matthew’s Correlation Coefficient, CD = Clavien Dindo classification of complications. AT = Anaerobic Threshold, VE/VCO2 = Ventilatory
equivalents of carbon dioxide, Peak VO2 = highest recorded oxygen uptake, VO2 Max = Maximal VO2 uptake, 30D Mortality = 30 Day mortality, MACE = Major adverse
cardiovascular events, IP CVS Mortality = Inpatient deaths from cardiac causes, ICU = Intensive Care Unit. If only sensitivity/specificity shown then these are published
figures extracted from the paper. Figures in parentheses show published values for sensitivity and specificity, mismatch to calculated—potentially due to double counting
of complications due to cutpoints used in published tables. Figures for unplanned ICU admission for Prentis excludes patients electively admitted to ICU.
https://doi.org/10.1371/journal.pone.0226480.t002
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Fig 2. Boxplots of calculated and published measures of test performance of anaerobic threshold in identification
of individuals who suffer specific post-operative complications (n = 17 Studies). Results are across heterogeneous
surgical populations and use a variety of cut-offs and outcome definitions. A: Performance for identification of
Mortality (up-to 30 day postoperatively), B: Cardiorespiratory complications (alone and/or in combination), C:
Unplanned ICU admission. For source data see Table 2.
https://doi.org/10.1371/journal.pone.0226480.g002
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Table 3. Assessment of prediction models in identified studies using the CHARMS checklist (CHecklist for critical appraisal and data extraction for systematic
reviews of prediction modelling studies.
Study Source Participants Outcomes Predictors Development Sample
Size
(EVR)
Missing Data Performance Evaluation
Nagamatsu
[37]
Cohort
(R)
Individuals
undergoing
oesophagectomy
97% M
Cardiorespiratory VO2 max
AT
VC
FEV1,
V50/V25 ratio,
DLCO, PaO2
Multiple regression,
unclear model
building strategy
91
(2.4)
N/A ROC
No AUC
Not done
Hartley
[29]
Cohort
(R/P)
84%M, 23% >80
undergoing open
and EVAR AAA
repair
Mortality(30D) Repair type
Sex, Age, DM, IHD,
HTN, Antiplatelets,
Statins, Anaemia,
Urea, Creatinine
AAA size &
location, AT, Peak
VO2, VE/VCO2
Univariable prior to
Multi, backwards
using AIC
451
(3.5)
Excl. if >15%
missing
Median
imputation for
continuous
classed as
absent if
unclear for
categorical
Not done Not done
Junejo [33] Cohort
(P)
Undergoing hepatic
resection >65 or
with complex
resection, average
age 71, 2:1M:F
Cardiorespiratory Age
ASA
BMI
RCRI
AT
VE/CO2,
Unclear. P threshold
for progression to
Multiple Regression
analysis of <0.1
mentioned
92
(19.5)
N/A Not done Not done
Ting [34] Cohort
(P)
Kidney transplant,
average age 42, 91%
living kidney
recipients, 60%
Male
Unplanned ICU BMI
Desensitisation
Age, Sex Months of
Dialysis, HTN,
Dyslipidemia, DM
Carotid-Femoral
PWV (m/s)
Augmentation
index
AT
Multivariable after
univariable P of
<0.10, FW and BW
step. BMI and
dialysis time incl. as
known confounders
of postop
cardiovascular state.
AT used as binary
value (11.3)
70
(4.7)
N/A AUC
HL test
Cross-
validation
(no details)
Snowden
[35]
Cohort
(P)
Consecutive for
open hepatic
resection, excluded
those unable to
obtain an AT
Mortality AT
Peak VO2
Peak Work
Peak HR,
Age, BMI, Sex IHD,
CVA, DM, CCF,
HTN, Asthma,
COPD RCRI
Univariable then
included those with
P<0.1, forward step
regression with
assessment of co-
linearity. Only
present final model
containing AT
alone.
389
(18)
N/A AUC Not done
Barakat
[27]
Cohort
(P)
Single centre study,
Male
preponderance
(89%), Unclear
percentage of
eligible population
sent for CPET
Cardiac
Respiratory
Age, Sex
Method of repair
AT
VO2 peak
VE/VCO2
Included set
variables, no
evidence of
progression from
univariable to
multivariable. No
process of model
simplification given.
130
(R = 4)
(C = 3)
Not stated Not done Not done
Lam [36] Cohort
(R)
Single centre, aimed
for all consecutive
patients undergoing
oesophagectomy for
cancer
Cardiorespiratory AT
Peak VO2
Type of Surgery
Gender
Comorbiditty
Smoking
Stage and histology
Adjuvant therapy
Included CPET
variables and all
with univariable p of
<0.10
80
(20)
Not stated Not done Not done
https://doi.org/10.1371/journal.pone.0226480.t003
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speciality (Upper GI, vascular, hepatobiliary, renal transplant) and, in one paper [27], an unclear
percentage of the eligible population were sent for CPET. Included covariates included CPET
variables (AT, VE/VCO2, VO2 peak, work parameters) as well as scoring systems (ASA score,
revised cardiac risk index), comorbidites, and specific medications. In four cases a clear process
of model development was followed with the inclusion of variables significant on univariable
analysis (normally p<0.1) or for pre-specified biological reasons, being included in initial multi-
variable models [29, 34–36]. At the end of model generation one study [35] simplified to using
AT alone as a predictor variable, and in one case [27] the process of model generation or simplifi-
cation was unclear. Median sample size was 123 [IQR: 93-168]. Three of the studies had event to
variable ratios (EVR) of above 10. An EVR of less than 10 is associated with a risk of ‘overfitting’
and generating a model with poor external validity [19]. Only two of the papers reported an
assessment of model performance. One reported tests of discrimination (AUC) and calibration
(Hosmer-Lemeshow) [34] with one reporting only a measure of discrimination (AUC) [35].
Only one study reported to have undertaken a process of internal evaluation of model perfor-
mance (unspecified cross-validation approach) [34], no model was verified in an external dataset.
AUC and other predictors
Nine studies reported AUC values for CPET variables. For mortality these ranged from 0.75
(AT) to 0.95 (VE/VCO2). Presented values for cardiorespiratory complications appeared lower
and ranged from 0.54 (Peak VO2) to 0.83 (AT). Full values are available in S1 Table. For seven
studies classifier measures for other predictors (e.g. ASA score) were presented, or calculated
(S2 Table). Potential predictors included blood tests, other scoring systems, or clinician deter-
mined high and low risk groups. For those studies looking at mortality [26, 28, 32, 33, 38], sen-
sitivity ranged from 44.4% (presence of a single cardiac risk factor) to 100% (study delineated
‘high risk group’ based on CPET referral criteria). In the paper by James et al [39]. AUCs for a
variety of other predictors were generated but no tests of significance between these and the
AUCs calculated for CPET variables was performed.
Discussion
To our knowledge, this is the first systematic review to extract and calculate comparable mea-
sures of CPET’s performance as a prognostic test. We feel this framing of CPETs performance
in familiar numerical terms is a key strength of our study as it provides a clear structure for
considering the implications of CPET’s performance in routine practice.
A key paper in the field was discovered during our repeat search [40]. This was a prospec-
tive trial of over 1300 patients in which CPET was compared to both subjective clinician
assessment and other objective methods of physical performance. Due to its importance we
reviewed it for inclusion in our systematic review but it failed to meet our inclusion criteria
due to its use of a pooled outcome of 30 day death and myocardial infarction. We will however
highlight key messages from this paper in the context of our other findings. We did include a
secondary analysis of this cohort where chronotropic incompetence during CPET was assessed
as a predictor of postoperative myocardial injury assessed using rises in serum troponin [41].
Classifier performance of CPET
The differences in calculated NPV and PPV across studies examining AT is particularly strik-
ing (Fig 2). Both NPV and PPV depend on the frequency of the complication within the popu-
lation, [42] being at their most extreme with a rare outcome (such as mortality). A gradual
reduction in NPV, and increase in PPV as complications become more frequent (e.g. cardiore-
spiratory complications) can be seen. We also generated two lesser known measure of classifier
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performance, the MCC and the F1 score [15]. Its interpretation is relatively intuitive. It is a
correlation coefficient, ranging from -1 to 1 with the two bounds representing a test that is
always incorrect, and one that is always correct. Importantly, given the paucity of events in
some studies, the measure is relatively resistant to class imbalance (i.e. low frequency of spe-
cific outcomes). We report a broad range (from -0.18 to 0.92) but with median values for our
differing complications all being less than 0.17 indicating, across all domains of patient classifi-
cation that CPET’s performance is relatively poor. Although no single measure of a test’s per-
formance can fully encompass its clinical utility, in the context of CPET the F1 score arguably
comes close. This is a score that equally weights the PPV and the sensitivity both of which, ide-
ally, should be high (i.e. a positive CPET test indicates a high likelihood of developing a com-
plication and that there are few false negatives). Across all outcomes and studies our estimates
ranged from 0.04 to 0.64 with 22/48 values being 0.20 or lower. As shown in Table 2 studies
with higher F1 scores demonstrated higher PPV. A deeper understanding of why these studies
exhibited better PPV could be vital in determining optimal use of CPET (e.g. was it due to spe-
cific procedures, recruitment measures, or derived indices). The F1 score weights both false
positives and false negatives equally but, depending on context this weighting can be adjusted
(the Fβ) score) [15]. We utilised equal weighting in the CPET context as although we would
like a sensitive measure, potential interventions (such as critical care beds), have a finite capac-
ity and thus could not accommodate unlimited numbers of people who will actually not suffer
a complication.
Our results suggest that most individuals with a ‘high-risk’ CPET result actually have a
greater chance of not suffering a complication than they are to suffer one. This poor rule-in
performance is important if decisions to not proceed to surgery are taken on the basis of such
a result. It is also highly relevant if a scarce resource (such as a critical care bed) is being allo-
cated preemptively based on a low likelihood of a complication occurring. Worse still, we have
no systematic information to suggest whether the allocation of a critical care resource in the
immediate post-operative period would be effective in preventing adverse events. Not only is
this impossible from such observational work, but this may also be determined by timings of
adverse events which may occur after a preemptive critical care admission is over.
Conversely, rule out performance is better, with a ‘low-risk’ CPET patient being unlikely to
suffer complications meaning, in the correct context, this could reassure clinicians about pro-
ceeding with surgery. Acceptable thresholds for NPV, and PPV in terms of gating further care
are open for discussion but should be considered in light of their potential benefits on the
shared decision-making process in the run up-to surgery. Overall our results would suggest
that CPET is better at ruling out complications (as indicated by its relatively high NPV) but
this is also likely influenced by the frequency of complications and the sample size within the
study in question. A nationwide survey in 2011 suggested that 33% of CPET centres may rec-
ommend cancellation based on CPET results, although in the majority of cases the results
form part of the overall shared decision making process [9]. From our results we cannot com-
ment specifically on CPET’s performance in this context although each result that we have cal-
culated will be dependent on the preceding stratification process which was highly variable
between studies (Table 1). Given its complexity in terms of organisation, staffing, and patient
attendance the justification of CPET over other stratification tools relies on a demonstration
that it offers additional benefit to patients and clinicians. An argument could be made, that in
a sufficiently ‘high-risk’ population the frequency of complications would increase to a point
that the NPV, and PPV of CPET would become more favourable. The correct method of doing
this is not apparent from our included studies. A cautionary note for such a strategy is the fact
that, in a population selected on the basis of cardiac risk factors, CPET offered no additional
discriminating capabilities on risk of cardiac complications or death [40].
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These, and other gaps in the literature have only recently been filled by the prospective,
multi-centre ‘METS’ (Measurement of Exercise Tolerance before Surgery) trial [40]. This fol-
lowed nearly 1,400 patients for one year after major, non-cardiac surgery, with daily examina-
tion for cardiac complications whilst an inpatient. They utilised the ‘net reclassification index’
to identify whether CPET, when added to baseline models of age, sex, cardiac risk factors, and
surgery type was able to correctly reclassify individuals at risk of complications. For their pri-
mary outcome of 30-day mortality or myocardial infarction they showed no additional prog-
nostic benefit of CPET derived variables. The only significant CPET variable was the addition
of peak oxygen consumption for the identification of those at risk of a composite of all moder-
ate to severe in-hospital complications. The study also assessed both the Duke Activity Score
Index (DASI), and NT-pro-BNP for improved identification of those at risk of their primary
outcome. Neither were significant for this outcome but, both demonstrated benefit at identify-
ing sub-clinical myocardial injury (as assessed by troponin assay). The METS study suggests
that CPET adds little to easily assessed baseline factors for predicting risk. An important caveat
might be the frequency of outcomes, with the study only having 28 individuals suffering their
composite primary outcome [40].
In addition, our study is the first to apply the CHARMS [20] criteria to regression models
generated using CPET variables. We critiqued models generated against any one of our pre-
specified outcomes. In general, generation, and assessment of regression models was incom-
plete. Only one study assessed internal validity (using cross-validation) and three of the
models were at risk of overfitting due to low event to variable (EVR) ratios. No model has
(from our results) ever been validated in a different patient cohort or used as a starting
point for refinement by subsequent authors. As such, generalising the findings of these anal-
yses is unfounded. The lack of clear outputs of model performance (such as discrimination,
and calibration) means that even internal validity may be difficult to determine in certain
cases.
The results of our systematic review indicate a broad range of estimates for CPET perfor-
mance as a prognostic test in non-cardiopulmonary surgery. The single centre, retrospective
nature of many of the studies limits the ability to generalize findings to everyday practice and
it is telling that the original paper identifying an AT of 11ml/kg/O2 as an important threshold
is now 25 years old and, arguably, may not be reflective of today’s surgical practice. It is telling
that, as highlighted in Table 1, many studies did not blind clinicians to the results of CPET,
introducing the potential for bias and confounding into their (and, subsequently, our) find-
ings. Nationally, CPET has been used to determine various components of perioperative care
including ICU admission, monitoring, or type of surgical procedure [9]. Some of these inter-
ventions (e.g. routine critical care for high risk individuals) could, arguably, bias findings
towards the null by having averted potential complications in the high-risk cohort. The fact
that 7 of 11 studies where CPET was explicitly or potentially stated to have not altered care,
failed to demonstrate significant associations with complications suggests this is unlikely to be
the whole truth.
Whilst our work illustrates that CPET alone is not a good predictor of adverse events our
results may not fully encompass the subtleties of its use within clinical practice. Certainly it is
possible that there exists a spectrum of use and it may be that CPET is of predictive value in a
subset of very high risk patients. Unfortunately, a lack of methodological standardization
makes this impossible to assess. Indeed, in our included studies there has been little or no sys-
tematic attempt to assess the incremental discrimination of CPET over and above other, per-
haps simpler assessments.
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Strengths and weaknesses of our approach
We acknowledge that due to the potential for bias and confounding within the primary studies
that our extracted and calculated estimates are, themselves, likely to be biased. We defend this
by arguing that the widespread adoption of CPET is arguably grounded in the interpretation
of these studies and that we are merely quantifying metrics which should be implicit in the
extrapolation of these studies to clinical practice. We judged that calculating classifier metrics
based on these studies was a valid approach as we focused on a single time period (the in-hos-
pital period) and that the majority of studies did not delineate the exact time a complication
was screened for or occurred. If raw data was available then use of Poisson or time to event
(e.g. Cox) regression techniques would be an alternative to demonstrate an association
between CPET variables and outcomes of interest. We feel that our use of classifier measures
in this prognostic context (which is supported in the literature [14]) offers a framework for
interpretation that can be directly related to clinical practice.
Our results are heterogeneous due to the plethora of settings, surgical sub-specialities, selec-
tion criteria, outcomes, and outcome definitions used. It is for this reason that we have taken
no steps to present a pooled or aggregate measure of CPET’s performance. This is an impor-
tant finding in itself and demonstrates a troubling lack of methodological standardisation in
the literature and presumably therefore perhaps also in how CPET is used clinically. Our initial
aim had been to only include studies utilising rigorously defined definitions of specific postop-
erative complications [21] but this had to be broadened to any named complication within this
document to allow for a suitable number of studies to be included. We justify this by saying
that any concerns we had with the chosen method of outcome definition is reflected in the
QUIPS score given to the study for that domain (S1 Fig). Our selection of outcomes for inclu-
sion was underpinned by physiological rationale and the utilisation of CPET in routine prac-
tice. We tried to minimise the use of composite outcomes to reduce heterogeneity in our
generated classifier metrics. We did extract pooled cardiorespiratory outcomes if so presented
due to the potential for crossover between these measures depending on the scoring system
used. For instance the postoperative morbidity score requires an individual to be on oxygen to
class as having a respiratory complication, which is highly likely to have occurred in the con-
text of an individual with heart failure (who would be classed as having a cardiovascular com-
plication) [21]. As a caveat to this, if multi domain scores like this were presented we
calculated the occurrence of cardiac and respiratory complications separately to minimise the
risk of double counting individuals. The use of composite outcomes is widespread especially as
they can lead to an increase in statistical power [43]. Issues with this approach are that any
effect may be interpreted by the reader to apply equally across all components of the compos-
ite, and that there should be an equivalent effect on each component. Furthermore, an interest-
ing area of further work would be to explore how valid the use of ‘all complications’ is from a
patient perspective, the presentation of information pertaining to such a composite is arguably
only at its most valid if the patient weighs the impact of each component equally.
We accept that in many of the included studies our outcome was not the author’s primary
outcome and this may introduce bias into our results by skewing indices such as sensitivity
and specificity (See calculations in S1 File). We hope that by providing full access to our calcu-
lations, including the location of generated numbers within the corresponding paper, that we
have provided sufficient information for clinicians to interpret our findings in context.
Conclusion
Our systematic review highlights potential limitations of CPET by generating common and
novel measures of test performance. Specifically, given the frequency of complications in
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studies we highlight the low values of PPV, although far from perfect for gating access to sur-
gery or critical care they may help inform a process of shared decision making prior to surgery.
The performance of CPET in day to day practice may be improved if a sufficiently high risk
population could be identified for it to be employed in. The high NPV offered by CPET may
be testament to accuracy of its underlying physiological rationale. However, based on our
results, and those from a recent high-quality prospective study [40] the precision of CPET for
reliably identifying individuals who will suffer postoperative cardiorespiratory complications
appears poor. Certainly, given the values of PPV we report it would be difficult to justify not
proceeding to surgery on the basis of a high-risk CPET test alone. Due to its role within the
wider system of perioperative assessment, optimisation, and postoperative care a nuanced
interpretation of its ability to rule-in and rule-out potential complications is justified.
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